Breast Cancer Metastatic
2 competing products in clinical development for Breast Cancer Metastatic.
Pipeline by Phase
Phase 1/21
Phase 21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Trastuzumab Deruxtecan | Daiichi Sankyo | Phase 2 | Recruiting | 42 |
| Patritumab deruxtecan + Olaparib | Daiichi Sankyo | Phase 1/2 | Recruiting | 39 |